Table 1.
The antimicrobial spectrum of phage CSA13.
| Bacterial Host | Lytic Activity a | Origin |
|---|---|---|
| Staphylococcal strains | ||
| S. aureus RN4220 | T | Laboratory strain |
| S. aureus Newman | I | Human |
| S. aureus ATCC 13301 | C | N/A |
| S. aureus ATCC 23235 | T | Food |
| S. aureus ATCC 33586 | T | Human |
| S. aureus ATCC 33593 | C | Human |
| S. aureus KCTC 1916 | C | Human |
| S. aureus ATCC 6538 | C | Human |
| S. aureus ATCC 29213 | C | Human |
| S. aureus ATCC 12600 | T | Human |
| MRSA CCARM 3793 | C | Human |
| MRSA CCARM 3089 | C | Human |
| MRSA CCARM 3090 | I | Human |
| S. haemolyticus ATCC 29970 | I | Human |
| S. epidermidis ATCC 35983 | C | Human |
| S. hominis ATCC 27844 | C | Human |
| S. warneri ATCC 10209 | T | Antibiosis indicator for snake venoms |
| Other Gram-positive bacteria | ||
| Enterococcus faecalis ATCC 29212 | - | Human |
| Bacillus cereus ATCC 14579 | - | Farmhouse |
| Bacillus subtilis ATCC 23857 | - | N/A |
| Listeria monocytogenes ATCC 19114 | - | Animal |
| Laboratory isolates (S. aureus) | ||
| 129 | C | Animal |
| 130 | T | Animal |
| 131 | T | Animal |
| 134 | C | Animal |
| Clinical isolate 0055 | C | Human |
| Clinical isolate 0136 | C | Human |
| Clinical isolate 0154 | T | Human |
| Clinical isolate 0212 | T | Human |
| Clinical isolate 0600 | C | Human |
| Clinical isolate-FMB_1 | C | Cotton from hospital |
| 77 | T | Human |
| 79 | T | Human |
| 80 | C | Human |
| 81 | T | Human |
| 82 | T | Human |
a C, clear plaque; T, turbid plaque; I, inhibition zone; -, no lytic effect.